Geriatric nutritional risk index (GNRI), a newly developed indicator of
nutritional status retrieved by serum albumin concentration and ideal body
weight, has been suggested as a prognostic factor for various malignancies. The
aim of the study was to summarize the prognostic role of GNRI for patients with
non-small cell lung cancer (NSCLC) in a meta-analysis. Cohort studies evaluating
the relationship between GNRI at baseline and survival OF NSCLC were retrieved
by search of PubMed, Embase, and Web of Science databases from inception to
January 12, 2022. A conservative random-effect model incorporating the possible
influence of between-study heterogeneity was used to pool the results. Eleven
cohorts including 2865 patients with NSCLC were included. Compared to those with
higher GNRI, NSCLC patients with lower GNRI were associated with poorer overall
survival [OS, hazard ratio (HR): 2.39, 95% CI: 1.97–2.91,
p<0.001; I2=29%), progression-free survival (HR: 1.94,
95% CI: 1.52–2.47, p<0.001; I2=29%), and
cancer-specific survival (HR: 2.59, 95% CI: 1.55–4.35,
p<0.001; I2=0%). Subgroup analyses showed that the
significant association between lower GNRI and worse OS in patients with NSCLC
was not affected by study characteristics including study location, design,
cancer stage, treatment, or follow-up durations (p for subgroup effects
all<0.001). In conclusion, a lower GNRI in patients with NSCLC may be a
predictor of poor survival. Nutritional status indicated by GNRI may be
important for the prognostic prediction of patients with NSCLC.